Cover Image

The Comprehensive Role of High Mobility Group Box 1 (HMGB1) Protein in Different Tumors: A Pan-Cancer Analysis

Hui Guan,1 Ming Zhong,1 Kongyang Ma,2 Chun Tang,1 Xiaohua Wang,1 Muzi Ouyang,3 Rencai Qin,2 Jiasi Chen,1 Enyi Zhu,1 Ting Zhu,1 Yongping Lu,1 Yu Liu,1 Chengzi Tian,4 Zhihua Zheng1 1Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Guan H (Author), Zhong M (Author), Ma K (Author), Tang C (Author), Wang X (Author), Ouyang M (Author), Qin R (Author), Chen J (Author), Zhu E (Author), Zhu T (Author), Lu Y (Author), Liu Y (Author), Tian C (Author), Zheng Z (Author)
Format:	Book
Published:	Dove Medical Press, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
by: Qingjie Chen, et al.
Published: (2016)

Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
by: Ruochan Chen, et al.
Published: (2013)

Increased Serum Concentrations of High Mobility Group Box 1 (HMGB1) Protein in Children with Autism Spectrum Disorder
by: Gerasimos Makris, et al.
Published: (2021)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
by: Huan Yang, et al.
Published: (2019)

Carbenoxolone Blocks Endotoxin-Induced Protein Kinase R (PKR) Activation and High Mobility Group Box 1 (HMGB1) Release
by: Wei Li, et al.
Published: (2013)

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
by: Huan Yang, et al.
Published: (2020)

Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
by: Huan Yang, et al.
Published: (2020)

Signaling of High Mobility Group Box 1 (HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD14
by: Sodam Kim, et al.
Published: (2013)

Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model
by: Lidan Luo, et al.
Published: (2022)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
by: Hiromi Abe, et al.
Published: (2023)

High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID‐19 patients: HMGB1 as a biomarker of worst prognosis
by: Amanda Roberta Revoredo Vicentino, et al.
Published: (2023)

Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives
by: Wei G, et al.
Published: (2022)

High Translocation of High Mobility Group Box 1 in the Brain Tissue of Patients with Sturge-Weber Syndrome
by: Cheng Z, et al.
Published: (2024)

The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury
by: Bai J, et al.
Published: (2022)

The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
by: Tao H, et al.
Published: (2019)

Analysis of glycyrrhizin binding to protein HMGB1
by: Gérard Vergoten, et al.
Published: (2020)

LPS Primes Brain Responsiveness to High Mobility Group Box-1 Protein
by: Verena Peek, et al.
Published: (2021)

HMGB1-RAGE signaling pathway in pPROM
by: Huan Yan, et al.
Published: (2018)

The Role of HMGB1 in Immunity
Published: (2020)

High Mobility Group Box 1 Protein Induction by Mycobacterium Bovis BCG
by: Péter Hofner, et al.
Published: (2007)

HMGB1/TLR4 Signaling Affects Regulatory T Cells in Acute Lung Injury
by: Zhou M, et al.
Published: (2021)

Pan-Cancer Analysis of Oncogenic Role of RAD54L and Experimental Validation in Hepatocellular Carcinoma
by: Zhou Y, et al.
Published: (2023)

Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis
by: Singh A, et al.
Published: (2015)

Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer
by: Chaojun Zhu, et al.
Published: (2024)

Integrative Pan-Cancer Analysis Reveals the Oncogenic Role of MND1 and Validation of MND1’s Role in Breast Cancer
by: Zhang W, et al.
Published: (2024)

Coactosin-Like Protein 1 (COTL1) Could Be an Immunological and Prognostic Biomarker: From Pan-Cancer Analysis to Low-Grade Glioma Validation
by: Wang X, et al.
Published: (2024)

Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage
by: Yu Zhou, et al.
Published: (2010)

Regulation of Autophagy-Related Protein and Cell Differentiation by High Mobility Group Box 1 Protein in Adipocytes
by: Huanhuan Feng, et al.
Published: (2016)

Prunella vulgaris L. Attenuates Experimental Autoimmune Thyroiditis by Inhibiting HMGB1/TLR9 Signaling
by: Guo Q, et al.
Published: (2021)

Elevated Serum HMGB1 Levels and Their Association with Recurrence of Acute Ischaemic Stroke
by: Shen L, et al.
Published: (2024)

Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study
by: Dan Xu, et al.
Published: (2021)

HMGB1-Induced Hepatocyte Pyroptosis Expanding Inflammatory Responses Contributes to the Pathogenesis of Acute-on-Chronic Liver Failure (ACLF)
by: Hou W, et al.
Published: (2021)

Extracellular HMGB-1 activates inflammatory signaling in tendon cells and tissues
by: Chuanxin Zhang, et al.
Published: (2020)

HMGB1 Localization during Experimental Periodontitis
by: Andressa Vilas Boas Nogueira, et al.
Published: (2014)

High mobility group box 1 inhibition by BoxA attenuates ovalbumin-induced allergic rhinitis in mice
by: Liyan Yue, et al.
Published: (2022)

Expression of high-mobility group box-1 in eutopic/ectopic endometrium and correlations with inflammation-related factors in adenomyosis
by: Xiu-Ni Liu, et al.
Published: (2023)

Hexafluoroisopropanol decreases liver ischemia-reperfusion injury by downregulation of high mobility group box‐1 protein
by: Agustin Vintimilla Moscoso, et al.
Published: (2022)

Sample Preparation Strategies for Antibody-Free Quantitative Analysis of High Mobility Group Box 1 Protein
by: Ingeborg Kvivik, et al.
Published: (2021)

Anabolic Properties of High Mobility Group Box Protein-1 in Human Periodontal Ligament Cells In Vitro
by: Michael Wolf, et al.
Published: (2014)

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
by: Zhu Y, et al.
Published: (2019)